CAS: 1380341-99-0
Ref: IN-DA009Z01
| 5mg | 159.00 € | ||
| 10mg | 177.00 € | ||
| 25mg | 267.00 € | ||
| 50mg | 488.00 € | ||
| 100mg | To inquire |
Estimated delivery in United States, on Friday 28 Mar 2025
Ref: 4Z-G-219002
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Friday 4 Apr 2025
Ref: 4Z-G-219001
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Friday 4 Apr 2025
GAL-021
CAS:1380341-99-0
GAL-021 an intravenous BKCa-channel blocker.
Formula:
C11H22N6O
Purity:
97.71% - 99.73%
Color and Shape:
Solid
Molecular weight:
254.33
Ref: TM-T3557
| 1mg | 37.00 € | ||
| 5mg | 74.00 € | ||
| 10mg | 103.00 € | ||
| 25mg | 187.00 € | ||
| 50mg | 283.00 € | ||
| 100mg | 437.00 € | ||
| 500mg | 938.00 € | ||
| 1mL*10mM (DMSO) | 85.00 € |
Estimated delivery in United States, on Friday 4 Apr 2025
N2-Methoxy-N2-methyl-N4,N6-dipropyl-1,3,5-triazine-2,4,6-triamine or ENA-001
Controlled ProductCAS:1380341-99-0
Formula:
C11H22N6O
Color and Shape:
Neat
Molecular weight:
254.34
Ref: TR-M563780
| 250mg | 1,136.00 € |
Estimated delivery in United States, on Thursday 8 May 2025
GAL-021
CAS:1380341-99-0
GAL-021 is an orally active compound that is being developed for the treatment of inflammatory …
Formula:
C11H22N6O
Purity:
Min. 95%
Molecular weight:
254.33 g/mol
Ref: 3D-FFC34199
| 5mg | Discontinued | Request information | |
| 10mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information | |
| 50mg | Discontinued | Request information | |
| 100mg | Discontinued | Request information |
